Coulie Bernard

CIK 00018088953 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001808895

Recent Transactions

50 trades

Award
Septerna, Inc.$SEPN
Stock Option (Right to Buy)
2026-06-26+15,000→ 15,000 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (Right to Buy)
2026-04-17+146,841→ 146,841 total
Disposition to Issuer
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (Right to Buy)
2026-04-17−440,000→ 0 total
Disposition to Issuer
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (Right to Buy)
2026-04-17−206,300→ 0 total
Disposition to Issuer
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (Right to Buy)
2026-04-17−325,000→ 0 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (Right to Buy)
2026-04-17+325,000→ 325,000 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (Right to Buy)
2026-04-17+327,262→ 327,262 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (Right to Buy)
2026-04-17+250,000→ 250,000 total
Disposition to Issuer
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (Right to Buy)
2026-04-17−146,841→ 0 total
Disposition to Issuer
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (Right to Buy)
2026-04-17−327,262→ 0 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (Right to Buy)
2026-04-17+206,300→ 206,300 total
Disposition to Issuer
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (Right to Buy)
2026-04-17−256,300→ 0 total
Disposition to Issuer
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (Right to Buy)
2026-04-17−250,000→ 0 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (Right to Buy)
2026-04-17+256,300→ 256,300 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (Right to Buy)
2026-04-17+440,000→ 440,000 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (Right to Buy)
2026-01-22+1,230,000→ 1,230,000 total
Sale
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2026-01-20$1.28/sh−89,375→ 505,601 total
Award
Septerna, Inc.$SEPN
Stock Option (Right to Buy)
2025-06-17+16,623→ 16,623 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2025-01-23+162,500→ 593,017 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (Right to Buy)
2025-01-23+325,000→ 325,000 total
Sale
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2025-01-17$11.20/sh−52,419→ 430,517 total
Sale
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2024-07-10$11.56/sh−38,710→ 482,936 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2024-07-09+75,625→ 521,646 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2024-01-23+128,150→ 444,532 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (Right to Buy)
2024-01-23+256,300→ 256,300 total
Sale
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2024-01-17$17.23/sh−25,721→ 316,382 total
Sale
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2023-07-17$18.01/sh−70,150→ 342,103 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2023-07-14+137,500→ 412,253 total
Award
SQZ Biotechnologies Co
Stock Option
2023-06-14+39,875→ 39,875 total
Sale
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2023-03-30$26.52/sh−35,339→ 274,753 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2023-03-29+68,749→ 310,092 total
Sale
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2023-02-03$33.36/sh−9,738→ 245,374 total
Exercise/Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (right to buy)
2023-02-03−15,000→ 327,262 total
Sale
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2023-02-03$34.08/sh−5,262→ 240,112 total
Exercise/Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2023-02-03$6.22/sh+15,000→ 255,112 total
Exercise/Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (right to buy)
2023-02-02−15,000→ 342,262 total
Sale
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2023-02-02$34.13/sh−13,395→ 241,717 total
Exercise/Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2023-02-02$6.22/sh+15,000→ 255,112 total
Sale
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2023-02-02$34.96/sh−1,605→ 240,112 total
Sale
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2023-02-01$35.55/sh−105→ 240,112 total
Exercise/Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2023-02-01$6.22/sh+15,000→ 255,112 total
Sale
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2023-02-01$34.15/sh−9,455→ 245,657 total
Sale
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2023-02-01$34.78/sh−5,440→ 240,217 total
Exercise/Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (right to buy)
2023-02-01−15,000→ 357,262 total
Sale
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2023-01-31$34.92/sh−15,000→ 240,112 total
Exercise/Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (right to buy)
2023-01-31−10,539→ 146,841 total
Exercise/Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (right to buy)
2023-01-31−4,461→ 372,262 total
Exercise/Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2023-01-31$6.22/sh+4,461→ 255,112 total
Exercise/Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2023-01-31$2.08/sh+10,539→ 250,651 total
Exercise/Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2023-01-30$2.08/sh+15,000→ 255,112 total

Companies

Recent Filings

Address

C/O SEPTERNA, INC. 250 EAST GRAND AVENUE

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov